tiprankstipranks

Jeffrey Farrow Insider Profile

4 Followers
Jeffrey Farrow, CFO at Hyperion Therapeutics, holds 26.74K shares in Global Blood Therapeutics (Ticker: GBT), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds ― shares in Tarsus Pharmaceuticals (Ticker: TARS). Most recently, Jeffrey Farrow Bought ― shares of Global Blood Therapeutics on Sep 29, 2022 for an estimated value of 387.91K.
tipranks
Jeffrey Farrow

Jeffrey Farrow
Hyperion Therapeutics (HPTX)
CFO

Not Ranked
Ranked #22,597 out of 97,825 Corporate Insiders
Jeffrey Farrow has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Jeffrey Farrow does not currently own shares as a corporate insider.
A breakdown of Jeffrey Farrow's holdings

Insider Roles

Tarsus Pharmaceuticals
(TARS)
CFO and Chief Strategy Officer
Roles that Jeffrey Farrow holds in companies

Most Profitable Insider Trade

Stock:
Global Blood Therapeutics
(GBT)
Rating:Informative Buy
Date:Nov 28, 2018 - Nov 28, 2019
Return:+102.00%
The most profitable trade made by Jeffrey Farrow

Jeffrey Farrow's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HPTX
Hyperion Therapeutics
May 07, 2015
Uninformative Sell
6.64M
GBT
Global Blood Therapeutics
Sep 29, 2022
Informative Buy
387.91K
$1.83M
Tarsus Pharmaceuticals
CFO and Chief Strategy Officer
ZSPH
ZS Pharma
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Farrow's performance on stock

Jeffrey Farrow insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Farrow?
The percentage of profitable transactions made by Jeffrey Farrow is ―.
    What is the average return per transaction made by Jeffrey Farrow?
    The average return per transaction made by Jeffrey Farrow is ―.
      What stocks does Jeffrey Farrow hold?
      Jeffrey Farrow holds: HPTX, GBT, TARS, ZSPH stocks.
        What was Jeffrey Farrow’s latest transaction?
        Jeffrey Farrow latest transaction was an Informative Buy of $387.91K.
          What was Jeffrey Farrow's most profitable transaction?
          Jeffrey Farrow’s most profitable transaction was an Informative Buy of GBT stock on November 28, 2018. The return on the trade was 102.00%.
            What is Jeffrey Farrow's role in Hyperion Therapeutics?
            Jeffrey Farrow's role in Hyperion Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.